You are on page 1of 1

Summary of the vulvovaginal candidiasis diagnostic and management pathway

Presentation Diagnostics Therapy

Microscopy for 1st line: fluconazole


Acute VVC
blastospore/ 150 mg PO stat; 2nd
pseudohyphae (in level line: clotrimazole
3 GUM setting) 500 mg PV[A]

Fluconazole Suppressive therapy


Microscopy susceptible with induction
and HVS for Candida (150 mg 3x/week)
Recurrent VVC fungal culture, then weekly 150 mg
(good/complete fluconazole for 6
identification (to at
response to Tx) months[A]
least C. albicans/
non-albicans),
sensitivity testing Fluconazole
for fluconazole resistant
Candida 100,000 IU nystatin
pessaries for 14
nights[A]

Microscopy
and HVS for
fungal culture, Azole resistant
identification and Candida
Recurrent VVC
full sensitivity
(poor/partial
response to Tx)
testing

600 mg boric acid


Nystatin pessaries for 14
resistant nights[A]
Candida

Consider alternative
or additional
diagnoses (lichen
sclerosus, vulval pain
syndromes, etc)

Abbreviations: GUM=genitourinary medicine, HVS=high vaginal swab, PO=per os (by mouth), PV=per
vagina, Tx=treatment, VVC=vulvovaginal candidiasis
[A] See relevant section in the full guideline for more detail and other treatment options

You might also like